Edition:
India

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

5,812.00GBp
18 Apr 2019
Change (% chg)

-56.00 (-0.95%)
Prev Close
5,868.00
Open
5,768.00
Day's High
5,847.00
Day's Low
5,757.00
Volume
1,659,843
Avg. Vol
1,413,730
52-wk High
7,174.00
52-wk Low
5,255.00

About

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East... (more)

Overall

Beta: 0.94
Market Cap(Mil.): £48,095.77
Shares Outstanding(Mil.): 703.57
Dividend: 66.60
Yield (%): --

Financials

  RB.L Industry Sector
P/E (TTM): 22.89 54.10 40.49
EPS (TTM): 2.99 -- --
ROI: 10.08 12.37 60.70
ROE: 27.55 15.52 72.00

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

(This April 10 story refiles to fix scrambled syntax in paragraph five)

11 Apr 2019

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

British drugmaker Indivior Plc lost nearly three-quarters of its share value on Wednesday and former parent Reckitt Benckiser also fell following U.S. criminal charges accusing Indivior of illegally increasing prescriptions for its opioid addiction treatment Suboxone.

11 Apr 2019

REFILE-UPDATE 6-Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

* Indivior charged in the United States with conspiracy, fraud

11 Apr 2019

Reckitt plays down Indivior risk to infant formula business

LONDON Reckitt Benckiser Group on Wednesday sought to play down any potential impact to its infant formula business from U.S. litigation against Indivior, which it used to own, saying the risk was theoretical and unlikely.

10 Apr 2019

Reckitt plays down Indivior risk to infant formula business

LONDON Reckitt Benckiser Group on Wednesday sought to play down any potential impact to its infant formula business from U.S. litigation against Indivior, which it used to own, saying the risk was theoretical and unlikely.

10 Apr 2019

Reckitt plays down Indivior risk to infant formula business

LONDON, April 10 Reckitt Benckiser Group on Wednesday sought to play down any potential impact to its infant formula business from U.S. litigation against Indivior , which it used to own, saying the risk was theoretical and unlikely.

10 Apr 2019

FTSE 100 little changed ahead of Brexit summit, Indivior tanks

* Indivior tanks after U.S. DoJ indictment, Reckitt also falls

10 Apr 2019

Reckitt Benckiser CEO gets hefty 2018 pay rise after sales improve

LONDON, April 2 Reckitt Benckiser's Chief Executive Rakesh Kapoor got a 69 percent pay rise last year, following an improvement in the company's performance after three tough years.

02 Apr 2019

UPDATE 1-UK Stocks-Factors to watch on Feb 19

Feb 19 Britain's FTSE 100 index is seen opening 8 points higher at 7,228 on Tuesday, according to financial bookmakers, while FTSE 100 futures were down 0.03 percent ahead of the cash market open.

19 Feb 2019

UK Stocks-Factors to watch on Feb 19

Feb 19 Britain's FTSE 100 index is seen opening 8 points higher at 7,228 on Tuesday, according to financial bookmakers. * RECKITT BENCKISER: British consumer goods group Reckitt Benckiser reported higher-than-expected sales growth on Monday, helped by improvements in both its health and home and hygiene businesses and lifting its shares to a two-month high. * BARCLAYS: Barclays will host more than 100 clinics for small business customers in March to help them to prepare f

19 Feb 2019

Earnings vs. Estimates